21
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Addressing the Missing Links in Cardiovascular Aging

, &
Pages 873-882 | Received 29 Dec 2023, Accepted 27 Apr 2024, Published online: 17 May 2024

References

  • Charo IF, Taub R. Anti-inflammatory therapeutics for the treatment of atherosclerosis. Nat Rev Drug Discov. 2011;10(5):365–376. PMID: 21532566; PMCID: PMC3947588. doi:10.1038/nrd3444
  • Dhingra R, Vasan RS. Age as a risk factor. Med Clin North Am. 2012;96(1):87–91. PMID: 22391253; PMCID: PMC3297980. doi:10.1016/j.mcna.2011.11.003
  • North BJ, Sinclair DA. The intersection between aging and cardiovascular disease. Circ Res. 2012;110(8):1097–1108. PMID: 22499900; PMCID: PMC3366686. doi:10.1161/CIRCRESAHA.111.246876
  • Roth G, Mensah G, Johnson C, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: update From the GBD 2019 Study. Journal of the American College of Cardiology. 2020;76(25):2982–3021. doi:10.1016/j.jacc.2020.11.010
  • Khot UN, Khot MB, Bajzer CT, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003;290(7):898–904. doi:10.1001/jama.290.7.898
  • Akosah K, Schaper A, Cogbill C, et al. Preventing myocardial infarction in the young adult in the first place: how do the national cholesterol education panel iii guidelines perform? J Am Coll Cardiol. 2003;41(9):1475–1479.
  • Schneider E, Shah E, Doty M, et al. Mirror, Mirror 2021: reflecting Poorly Health Care in the U.S. Compared to Other High-Income Countries. Commonwealth Fund. 2021:2:2.
  • Houston M. The role of noninvasive cardiovascular testing, applied clinical nutrition and nutritional supplements in the prevention and treatment of coronary heart disease. Ther Adv Cardiovasc Dis. 2018;12(3):85–108. PMID: 29316855; PMCID: PMC5933539. doi:10.1177/1753944717743920
  • Cervantes Gracia K, Llanas-Cornejo D, Husi H. CVD and Oxidative Stress. J Clin Med. 2017;6(2):22. PMID: 28230726; PMCID: PMC5332926. doi:10.3390/jcm6020022
  • Schulman IH, Balkan W, Hare JM. Mesenchymal Stem Cell Therapy for Aging Frailty. Front Nutr. 2018;5:108. PMID: 30498696; PMCID: PMC6249304. doi:10.3389/fnut.2018.00108
  • Bull MJ, Plummer NT. Part 1: the human gut microbiome in health and disease. Integr Med. 2014;13(6):17–22. PMID: 26770121; PMCID: PMC4566439.
  • Ghosh TS, Shanahan F, O’Toole PW. The gut microbiome as a modulator of healthy ageing. Nat Rev Gastroenterol Hepatol. 2022;19:565–584. doi:10.1038/s41575-022-00605-x
  • Valdes AM, Walter J, Segal E, Spector TD. Role of the gut microbiota in nutrition and health. BMJ. 2018;361:k2179. doi:10.1136/bmj.k2179
  • Rinninella E, Raoul P, Cintoni M, et al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms. 2019;7(1):14. PMID: 30634578; PMCID: PMC6351938. doi:10.3390/microorganisms7010014
  • Nagpal R, Mainali R, Ahmadi S, et al. Gut microbiome and aging: physiological and mechanistic insights. Nutr Healthy Aging. 2018;4(4):267–285. PMID: 29951588; PMCID: PMC6004897. doi:10.3233/NHA-170030
  • Toya T, Corban MT, Marrietta E, et al. Coronary artery disease is associated with an altered gut microbiome composition. PLoS One. 2020;15:e0227147. doi:10.1371/journal.pone.0227147
  • Choroszy M, Litwinowicz K, Bednarz R, et al. Human gut microbiota in coronary artery disease: a systematic review and meta-analysis. Metabolites. 2022;12(12):1165. PMID: 36557203; PMCID: PMC9788186. doi:10.3390/metabo12121165
  • Arboleya S, Watkins C, Stanton C, Ross RP. Gut bifidobacteria populations in human health and aging. Front Microbiol. 2016;7:1204. PMID: 27594848; PMCID: PMC4990546. doi:10.3389/fmicb.2016.01204
  • De Filippo C, Cavalieri D, Di Paola M. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA. 2010;107:14691–14696. doi:10.1073/pnas.1005963107
  • González F, Considine RV, Abdelhadi OA, Acton AJ. Saturated fat ingestion promotes lipopolysaccharide-mediated inflammation and insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab. 2019;104(3):934–946. PMID: 30590569; PMCID: PMC6364509. doi:10.1210/jc.2018-01143
  • Lagier JC. Human gut microbiota: repertoire and variations. Front Cell Infect Microbiol. 2012;2:136. doi:10.3389/fcimb.2012.00136
  • Bowman JD, Surani S, Horseman MA. Endotoxin, Toll-like Receptor-4, and Atherosclerotic Heart Disease. Curr Cardiol Rev. 2017;13(2):86–93. PMID: 27586023; PMCID: PMC5452150. doi:10.2174/1573403X12666160901145313
  • Wu HJ, Wu E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes. 2012;3(1):4–14. PMID: 22356853; PMCID: PMC3337124. doi:10.4161/gmic.19320
  • Moludi J, Maleki V, Jafari-Vayghyan H, et al. Metabolic endotoxemia and cardiovascular disease: a systematic review about potential roles of prebiotics and probiotics. Clin Exp Pharmacol Physiol. 2020;47(6):927–939. PMID: 31894861. doi:10.1111/1440-1681.13250
  • Gatarek P, Kaluzna-Czaplinska J. Trimethylamine N-oxide (TMAO) in human health. EXCLI J. 2021;20:301–319. PMID: 33746664; PMCID: PMC7975634. doi:10.17179/excli2020-3239
  • Witkowski W, Weeks TL, Hazen SL. Gut microbiota and cardiovascular disease. Circulation Res. 2020;127(4):553–570.
  • Wang Z. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472:57–63.
  • Guasti L, Galliazzo S, Molaro M, et al. TMAO as a biomarker of cardiovascular events: a systematic review and meta-analysis. Intern Emerg Med. 2021;16(1):201–207. Epub 2020 Aug 10. PMID: 32779113. doi:10.1007/s11739-020-02470-5
  • Li N, Zhou J, Wang Y, et al. Association between trimethylamine N-oxide and prognosis of patients with acute myocardial infarction and heart failure. ESC Heart Fail. 2022;9(6):3846–3857. doi:10.1002/ehf2.14009
  • Assefa S, Köhler G. Intestinal microbiome and metal toxicity. Curr Opin Toxicol. 2020;19:21–27. PMID: 32864518; PMCID: PMC7450720. doi:10.1016/j.cotox.2019.09.009
  • Naruszewicz M, Johansson ML, Zapolska-Downar D, Bukowska H. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am J Clin Nutr. 2002;76(6):1249–1255. PMID: 12450890. doi:10.1093/ajcn/76.6.1249
  • Barreto FM, Colado Simão AN, Morimoto HK, Batisti Lozovoy MA, Dichi I, Helena da Silva Miglioranza L. Beneficial effects of Lactobacillus plantarum on glycemia and homocysteine levels in postmenopausal women with metabolic syndrome. Nutrition. 2014;30(7–8):939–942. PMID: 24613434. doi:10.1016/j.nut.2013.12.004
  • Hendijani F, Akbari V. Probiotic supplementation for management of cardiovascular risk factors in adults with type II diabetes: a systematic review and meta-analysis. Clin Nutr. 2018;37(2):532–541. PMID: 28318686. doi:10.1016/j.clnu.2017.02.015
  • Zhao L, Zhang F, Ding X, et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science. 2018;359(6380):1151–1156. PMID: 29590046. doi:10.1126/science.aao5774
  • Malik M, Suboc TM, Tyagi S, et al. Lactobacillus plantarum 299v supplementation improves vascular endothelial function and reduces inflammatory biomarkers in men with stable coronary artery disease. Circ Res. 2018;123(9):1091–1102. PMID: 30355158; PMCID: PMC6205737. doi:10.1161/CIRCRESAHA.118.313565
  • Cantero MA, Guedes MRA, Fernandes R, Lollo PCB. Trimethylamine N-oxide reduction is related to probiotic strain specificity: a systematic review. Nutr Res. 2022;104:29–35. PMID: 35588611. doi:10.1016/j.nutres.2022.04.001
  • Eman M, Alissa, Gordon A. Ferns, heavy metal poisoning and cardiovascular disease. J Toxicol. 2011;2011:21. doi:10.1155/2011/870125
  • Hamanaka RB, Mutlu GM. Particulate matter air pollution: effects on the cardiovascular system. Front Endocrinol. 2018;9:680. PMID: 30505291; PMCID: PMC6250783. doi:10.3389/fendo.2018.00680
  • Lamas GA, Ujueta F, Navas-Acien A. Lead and Cadmium as cardiovascular risk factors: the burden of proof has been met. J Am Heart Assoc. 2021;10(10). doi:10.1161/JAHA.120.018692
  • Roman HA, Walsh TL, Coull BA, et al. Evaluation of the cardiovascular effects of methylmercury exposures: current evidence supports development of a dose-response function for regulatory benefits analysis. Environ Health Perspect. 2011;119(5):607–614. PMID: 21220222; PMCID: PMC3094409. doi:10.1289/ehp.1003012
  • Moon K, Guallar E, Navas-Acien A. Arsenic exposure and cardiovascular disease: an updated systematic review. Curr Atheroscler Rep. 2012;14:542–555. doi:10.1007/s11883-012-0280-x
  • Eum KD, Weisskopf MG, Nie LH, Hu H, Korrick SA. Cumulative lead exposure and age at menopause in the Nurses’. Environ Health Perspect. 2014;122(3):229–234. PMID: 24398113; PMCID: PMC3948024. doi:10.1289/ehp.1206399
  • Reeves PG, Chaney RL. Marginal nutritional status of zinc, iron, and calcium increases cadmium retention in the duodenum and other organs of rats fed rice-based diets. Environ Res. 2004;96:311–322. doi:10.1016/j.envres.2004.02.013
  • Larsson SE, Piscator M. Effect of cadmium on skeletal tissue in normal and calcium-deficient rats. Isr J Med Sci. 1971;7:495–498.
  • Hammad TA, Sexton M, Langenberg P. Relationship between blood lead and dietary iron intake in preschool children: a cross-sectional study. Ann Epidemiol. 1996;6:30–33. doi:10.1016/1047-2797(95)00097-6)
  • Zhai Q, Narbad A, Chen W. Dietary strategies for the treatment of cadmium and lead toxicity. Nutrients. 2015;7(1):552–571. PMID: 25594439; PMCID: PMC4303853. doi:10.3390/nu7010552
  • Lamas GA, Boineau R, Goertz C, et al. EDTA chelation therapy alone and in combination with oral high-dose multivitamins and minerals for coronary disease: the factorial group results of the trial to assess chelation therapy. Am Heart J. 2014;168(1):37–44.e5.
  • Sears ME, Kerr KJ, Bray RI. Arsenic, cadmium, lead, and mercury in sweat: a systematic review. J Environ Public Health. 2012;2012:184745. PMID: 22505948; PMCID: PMC3312275. doi:10.1155/2012/184745
  • Blum N, Blum A. Beneficial effects of sauna bathing for heart failure patients. Exp Clin Cardiol. 2007;12(1):29–32. PMID: 18650976; PMCID: PMC2359619.
  • Laukkanen T, Khan H, Zaccardi F, Laukkanen JA. Association between sauna bathing and fatal cardiovascular and all-cause mortality events. JAMA Intern Med. 2015;175(4):542–548. doi:10.1001/jamainternmed.2014.8187
  • Bisanz JE, Enos MK, Mwanga JR, et al. Randomized open-label pilot study of the influence of probiotics and the gut microbiome on toxic metal levels in Tanzanian pregnant women and school children. mBio. 2014;5(5):e01580–14. PMID: 25293764; PMCID: PMC4196227. doi:10.1128/mBio.01580-14
  • Ravalli F, Vela Parada X, Ujueta F, et al. Chelation therapy in patients with cardiovascular disease: a systematic review. J Am Heart Assoc. 2022;11(6):e024648. PMID: 35229619; PMCID: PMC9075296. doi:10.1161/JAHA.121.024648
  • Li Z, Jiang W. Acute and short-term efficacy of sauna treatment on cardiovascular function: a meta-analysis: reply. Eur J Cardiovasc Nurs. 2021;20(7):730. PMID: 34329397. doi:10.1093/eurjcn/zvab050
  • Lee E, Kolunsarka I, Kostensalo J, et al. Effects of regular sauna bathing in conjunction with exercise on cardiovascular function: a multi-arm, randomized controlled trial. Am J Physiol Regul Integr Comp Physiol. 2022;323(3):R289–R299. PMID: 35785965; PMCID: PMC9394774. doi:10.1152/ajpregu.00076.2022
  • Daugherty S, Blair I, Havranek E, et al. Implicit Gender bias and the use of cardiovascular tests among cardiologists. J Am Heart Assoc. 2017;6:12.
  • Rodgers JL, Jones J, Bolleddu SI, et al. Cardiovascular Risks Associated with Gender and Aging. J Cardiovasc Dev Dis. 2019;6(2):19. PMID: 31035613; PMCID: PMC6616540. doi:10.3390/jcdd6020019
  • Colditz GA, Willett W, Stampfer M, et al. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987;(316):1105–1110. doi:10.1056/NEJM198704303161801
  • Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses’ health study. N Engl J Med. 1991;325(11):756–762. PMID: 1870648. doi:10.1056/NEJM199109123251102
  • Hasan AS, Luo L, Baba S, Li TS. Estrogen is required for maintaining the quality of cardiac stem cells. PLoS One. 2021;16(1):e0245166. PMID: 33481861; PMCID: PMC7822545. doi:10.1371/journal.pone.0245166
  • Calabrese EJ. Hormesis and Endothelial Progenitor Cells. Dose Response. 2022;20(1):15593258211068625. PMID: 35221821; PMCID: PMC8874175. doi:10.1177/15593258211068625
  • Hodis HN, Mack WJ, Henderson VW, et al. Vascular effects of early versus late postmenopausal treatment with estradiol. N Engl J Med. 2016;374(13):1221–1231.
  • Arnson Y, Rozanski A, Gransar H, et al. Hormone Replacement Therapy Is Associated With Less Coronary Atherosclerosis And Lower Mortality. J Am Coll Cardiol. 2017;69(11_Supplement):1408.
  • Mikkola TS, Tuomikoski P, Lyytinen H, et al. Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality. Menopause. 2015;22(9):976–983. PMID: 25803671. doi:10.1097/GME.0000000000000450
  • Campagnoli C, Clavel-Chapelon F, Kaaks R, Peris C, Berrino F. Progestins and progesterone in hormone replacement therapy and the risk of breast cancer. J Steroid Biochem Mol Biol. 2005;96(2):95–108. PMID: 15908197; PMCID: PMC1974841. doi:10.1016/j.jsbmb.2005.02.014
  • Ralf P. Brandes and others, Endothelial aging. Cardiovascular Res. 2005;66(2):286–294. doi:10.1016/j.cardiores.2004.12.027
  • Boardman HM, Hartley L, Eisinga A, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev. 2015;3:CD002229.
  • Stephenson K, Neuenschwander PF, Kurdowska AK. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women. Int J Pharm Compd. 2013;17(1):74–85. PMID: 23627249.
  • Holtorf K. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy? Postgrad Med. 2009;121(1):73–85. PMID: 19179815. doi:10.3810/pgm.2009.01.1949
  • The North American Menopause Society. Menopause: The Journal of the North American Menopause Society. Vol. 29. © 2022 by The North American Menopause Society; 2022. 767–794. doi:10.1097/GME.0000000000002028
  • Files J, Kling JM. Transdermal delivery of bioidentical estrogen in menopausal hormone therapy: a clinical review. Expert Opin Drug Deliv. 2020;17(4):543–549. PMID: 31795776. doi:10.1080/17425247.2020.1700949
  • Barlow DH. HRT and osteoporosis. Baillieres Clin Rheumatol. 1993;7(3):535–548. PMID: 8293488. doi:10.1016/s0950-3579(05)80077-9
  • Dickinson J. Deadly medicines and organized crime: how big pharma has corrupted healthcare. Can Fam Physician. 2014;60(4):367–368. PMCID: PMC4046551.
  • Bajelan M, Etehad Roodi N, Hasanzadeh Daloee M, Farhangnia M, Samadi Kuchaksaraei A. The effect of low testosterone and estrogen levels on progressive coronary artery disease in men. Rep Biochem Mol Biol. 2019;8(2):168–171. PMID: 31832441; PMCID: PMC6844610.
  • Fleta-Asín B. Estrógenos y enfermedad cardiovascular en el varón [Estrogens and cardiovascular disease in the male]. Rev Esp Cardiol. 2007. 60(6):667–668. Spanish. PMID: 17580059. doi:10.1157/13107127
  • Gordon JL, Rubinow DR, Watkins L, Hinderliter AL, Caughey MC, Girdler SS. The effect of perimenopausal transdermal estradiol and micronized progesterone on markers of risk for arterial disease. J Clin Endocrinol Metab. 2020;105(5):e2050–60. PMID: 31838497; PMCID: PMC7096310. doi:10.1210/clinem/dgz262
  • Mittal M, McEniery C, Supramaniam PR. Impact of micronised progesterone and medroxyprogesterone acetate in combination with transdermal oestradiol on cardiovascular markers in women diagnosed with premature ovarian insufficiency or an early menopause: a randomised pilot trial. Maturitas. 2022;161:18–26.
  • Karim R, Xu W, Kono N, et al. Effect of menopausal hormone therapy on arterial wall echomorphology: results from the Early versus Late Intervention Trial with Estradiol (ELITE). Maturitas. 2022;162:15–22. PMID: 35474254; PMCID: PMC9232990. doi:10.1016/j.maturitas.2022.02.007
  • Bontempo S, Yeganeh L, Giri R, Vincent AJ. Use of MHT in women with cardiovascular disease: a systematic review and meta-analysis. Climacteric. 2024;27(1):93–103. PMID: 37933495. doi:10.1080/13697137.2023.2273524
  • Strijdom H, Chamane N, Lochner A. Nitric oxide in the cardiovascular system: a simple molecule with complex actions. Cardiovasc J Afr. 2009;20(5):303–310. PMID: 19907806; PMCID: PMC3721819.
  • Houston Marc C. Personalized and Precision Integrative Cardiovascular Medicine, 1e. Wolters Kluwer Health, 2019. Chapter 2, p6-18.
  • Szlachcic A, Krzysiek-Maczka G, Pajdo R, et al. The impact of asymmetric dimethylarginine (ADAMA), the endogenous nitric oxide (NO) synthase inhibitor, to the pathogenesis of gastric mucosal damage. Curr Pharm Des. 2013;19(1):90–97. PMID: 22950506. doi:10.2174/13816128130113
  • Esmaeilzadeh F. Does intermittent fasting improve microvascular endothelial function in healthy middle-aged subjects? Biol Med. 2016;8. doi:10.4172/0974-8369.1000337
  • Houston M, Hays L. Acute effects of an oral nitric oxide supplement on blood pressure, endothelial function, and vascular compliance in hypertensive patients. J Clin Hypertens. 2014;16(7):524–529. PMID: 24962851; PMCID: PMC8031495. doi:10.1111/jch.12352
  • Hutchings DC, Anderson SG, Caldwell JL, Trafford AW. Phosphodiesterase-5 inhibitors and the heart: compound cardioprotection? Heart. 2018;104(15):1244–1250. PMID: 29519873; PMCID: PMC6204975. doi:10.1136/heartjnl-2017-312865
  • Andersson D, Landucci L, Lagerros Y, et al. Association of phosphodiesterase-5 inhibitors versus alprostadil with survival in men with coronary artery disease. J Am Coll Cardiol. 2021;77(12):1535–1550.
  • Yang S, Li X, Yang F, et al. Gut microbiota- dependent marker TMAO in promoting cardiovascular disease: inflammation mechanism, clinical prognostic, and potential as a therapeutic target. Front Pharmacol. 2019;10:1360. doi:10.3389/fphar.2019.01360
  • Dyck GJB, Raj P, Zieroth S, Dyck JRB, Ezekowitz JA. The effects of resveratrol in patients with cardiovascular disease and heart failure: a narrative review. Int J Mol Sci. 2019;20(4):904. PMID: 30791450; PMCID: PMC6413130. doi:10.3390/ijms20040904
  • Fogacci F, Tocci G, Presta V, Effect of resveratrol on blood pressure: a systematic review and meta-analysis of randomized, controlled, clinical trials. Crit. Rev. Food Sci. Nutr. 2019;59(10):1605–1618. doi:10.1080/10408398.2017.1422480
  • Wong RH, Berry NM, Coates AM, et al. Chronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults. J Hypertens. 2013;31(9):1819–1827. PMID: 23743811. doi:10.1097/HJH.0b013e328362b9d6
  • Yadollahi A, Dastani M, Zargaran B, Ghasemi AH, Rahimi HR. The beneficial effects of curcumin on cardiovascular diseases and their risk factors. Rev Clin Med. 2019;6(1):12–19. doi:10.22038/rcm.2019.33520.1242
  • Sabira Mohammed KB. Harikumar, Chapter 8 - Antioxidant Properties of Curcumin: Impact on Neurological Disorders. Curcumin for Neurological and Psychiatric Disorders, Academic Press; 2019:155–167.
  • Sugawara J, Akazawa N, Miyaki A, et al. Effect of endurance exercise training and curcumin intake on central arterial hemodynamics in postmenopausal women: pilot study. Am J Hypertens. 2012;25:651–656. doi:10.1038/ajh.2012.24
  • Akazawa N, Choi Y, Miyaki A, et al. Curcumin ingestion and exercise training improve vascular endothelial function in postmenopausal women. Nutri Res. 2012;32:795–799. doi:10.1016/j.nutres.2012.09.002
  • Chuengsamarn S, Rattanamongkolgul S, Luechapudiporn R, Phisalaphong C, Jirawatnotai S. Curcumin extract for prevention of type 2 diabetes. Diabetes Care. 2012;35(11):2121–2127. PMID: 22773702; PMCID: PMC3476912. doi:10.2337/dc12-0116
  • Alizadeh M, Kheirouri S. Curcumin reduces malondialdehyde and improves antioxidants in humans with diseased conditions: a comprehensive meta-analysis of randomized controlled trials. Biomedicine. 2019;9(4):23. PMID: 31724938; PMCID: PMC6855189. doi:10.1051/bmdcn/2019090423
  • Zaky A, Bassiouny A, Farghaly M, El-Sabaa BM. A Combination of Resveratrol and Curcumin is Effective Against Aluminum Chloride-Induced Neuroinflammation in Rats. J Alzheimers Dis. 2017;60(s1):S221–S235. PMID: 28222524. doi:10.3233/JAD-161115